XKEM --------Federal Government has approved the sum of $28 million as counterpart commitment for the project.---------- Market CAP of XKEM 3 millions Very Undervalue ! Ready to Fly 0.010 cents !: XKEM ---- Last chance to BUY BUY BUY under 0.02 cents ----- BUY CONFIRMED
XKEM ----- 127 million Volume NEW RECORD -- UP 25% - BUY BUY BUY ALERT ALERT Last time to BUY UNDER 0.02 cents ------Short TIME Prize target Above 0.03 under 0.05 cents !
XKEM alert The SouthEnd Stock Pickers helps investors win at investing on the merits of radically original thinking and an unbeatable track record of picking stocks with huge potential. We're here for you with commonsense, the big ideas, and a little inspiration to turn your portfolio into a monster performer. We've brought you GTE, GOOG, SIRI, CMGI, JDSU,HISC, and others you've made a killing on! If it doesn't make commonsense, it makes nosense to us or you. At SouthEnd Stock Pickers, we're focusing solely on undervalued Nasdaq stocks that we feel will return potential profits of 500%+ in 1 to 3 weeks. Our New picks have hours and hours of research listed below.Our SouthEnd Team uses a new breakthrough method of hardcore stock picks.$$ WE ARE HERE TO MAKE YOU MONEY $$ Our new pick for 22/FEB/2006 is =(XKEM) was picked up of (INSIDER BUYING) Accumulation........is the key word Xechem International,Inc, Ticker Symbol = XKEM Market Cap = $ 1. 90M Industry: Biotechnology Target Price = $ 0.24 Recommendation: SUPER MEGA BUY There are many reasons to buy into (XKEM) $DO YOUR DD A HUGE WINNER HERE $ Once News on the Approval of the NIGERIA plant comes out SKY HIGH SHE GOES . Charts speak for them selfs RSI strong buy http://www.freewebs.com/stocktip/index.htm http://stockcharts.com/h-sc/ui?s=xkem Web Site: http://www.xechem.com Xechem Closes On $4.2 Million Lawsuit Settlement With Bristol-Meyers Squibb Xechem International, Inc. (OTC BB: XKEM) Xechem International said today that the $4.2 million settlement of its antitrust lawsuit against Bristol-Meyers Squibb Co., announced December 2005, has closed and that the net settlement proceeds have now been received by the company. (For more information regarding the settlement, including the allocation of proceeds, please refer to the Company's previously filed Form 8-K of public record.) The lawsuit, filed against Bristol-Meyers in federal district court in Chicago in 2003, centered on allegations that Bristol-Meyers had engaged in anticompetitive practices relating to Xechem's efforts to manufacture and bring to market the drug paclitaxel, a generic equivalent of Bristol's cancer drug, TAXOL(R). Bristol-Meyers did not admit to any wrongdoing as part of the settlement. Settlement Proceeds To Be Used To Further Restructuring Objectives and Xechem's Efforts to Launch Sickle Cell Drug Dr. Ramesh C. Pandey, Xechem's chairman and CEO, said that the money received by Xechem would be used, in part, to consummate Xechem's previously announced restructuring with Alembic Limited and in part to move Xechem closer to its goal of launching NICOSAN(TM)/HEMOXIN(TM), its promising sickle cell drug: "In anticipation of this Bristol settlement, we recently entered into a restructuring agreement with Alembic Ltd. which calls for the release of Alembic's significant equity stake in our Nigerian subsidiary and the cancellation of a significant 15-year gross royalty from the future sales of our sickle cell drug in exchange for accelerated debt repayment and certain collateral security. We intend to use a portion of the settlement monies to meet our obligations under that restructuring, with most of the rest of the money to be used to move us closer to our goal of commercially launching the sickle cell drug." Xechem has previously reported that it plans to bring NICOSAN(TM) to the Nigerian market in early 2006, and at the same time, embark on the clinical trials in the US hospitals for FDA approval through the Investigational New Drug (IND) Application for sale of the drug in the United States
charles wilson <profitablestock@yahoo.com> escribió: UPDA closed .26 but in AH .288 run is inminent...news coming on monday and oil price climbing fast
__________________________________________________ Do You Yahoo!? Tired of spam? Yahoo! Mail has the best spam protection around http://mail.yahoo.com
[Non-text portions of this message have been removed]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.